Terms: = Liver cancer AND ESR1, ESR, 2099, ENSG00000091831, RP1-130E4_1, NR3A1, ESRA, DKFZp686N23123, ER, Era AND Treatment
32992 results:
1. Outcomes of Y90 Radioembolization for Hepatocellular Carcinoma in Patients Previously Treated with Transarterial Embolization.
Zhao K; Son S; Karimi A; Marinelli B; Erinjeri JP; Alexander ES; Sotirchos VS; Harding JJ; Soares KC; Ziv E; Covey A; Sofocleous CT; Yarmohammadi H
Curr Oncol; 2024 May; 31(5):2650-2661. PubMed ID: 38785481
[TBL] [Abstract] [Full Text] [Related]
2. Borax affects cellular viability by inducing ER stress in hepatocellular carcinoma cells by targeting SLC12A5.
Hacioglu C; Oral D
J Cell Mol Med; 2024 May; 28(10):e18380. PubMed ID: 38780503
[TBL] [Abstract] [Full Text] [Related]
3. ULK1 Mediated Autophagy-Promoting Effects of Rutin-Loaded Chitosan Nanoparticles Contribute to the Activation of NF-κB Signaling Besides Inhibiting EMT in Hep3B Hepatoma Cells.
Wu P; Wang X; Yin M; Zhu W; Chen Z; Zhang Y; Jiang Z; Shi L; Zhu Q
Int J Nanomedicine; 2024; 19():4465-4493. PubMed ID: 38779103
[TBL] [Abstract] [Full Text] [Related]
4. Methylation-regulated tumor suppressor gene PDE7B promotes HCC invasion and metastasis through the PI3K/AKT signaling pathway.
Du Y; Xu Y; Guo X; Tan C; Zhu X; Liu G; Lyu X; Bei C
BMC Cancer; 2024 May; 24(1):624. PubMed ID: 38778317
[TBL] [Abstract] [Full Text] [Related]
5. Outcomes and Recurrence Rate of Esophageal Varices after Endoscopic treatment in Patients with Alcoholic Cirrhosis and Viral Cirrhosis.
Furuichi Y; Nishiguchi R; Shimakawa T; Fujiwara T; Sato K; Kato H
J Nippon Med Sch; 2024; 91(2):180-189. PubMed ID: 38777781
[TBL] [Abstract] [Full Text] [Related]
6. Blocking the angiopoietin-2-dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasis.
Meder L; Orschel CI; Otto CJ; Koker M; Brägelmann J; Ercanoglu MS; Dähling S; Compes A; Selenz C; Nill M; Dietlein F; Florin A; Eich ML; Borchmann S; Odenthal M; Blazquez R; Hilberg F; Klein F; Hallek M; Büttner R; Reinhardt HC; Ullrich RT
JCI Insight; 2024 May; 9(10):. PubMed ID: 38775153
[TBL] [Abstract] [Full Text] [Related]
7. Comparative Study of the Short-Term Efficacy and Safety between DEB-TACE and C-TACE in the treatment of Unresectable Hepatocellular Carcinoma, a Retrospective Study.
Hai L; Liu S; Ma L; Ding X; Bai X; Luo X
Technol Cancer Res Treat; 2024; 23():15330338241250315. PubMed ID: 38773767
[No Abstract] [Full Text] [Related]
8. Role of peritumoral tissue analysis in predicting characteristics of hepatocellular carcinoma using ultrasound-based radiomics.
Qian H; Huang Y; Xu L; Fu H; Lu B
Sci Rep; 2024 May; 14(1):11538. PubMed ID: 38773179
[TBL] [Abstract] [Full Text] [Related]
9. Experimental validation of the accuracy of robotic-assisted radioactive seed implantation for tumor treatment.
Ji Z; Wang Z; Jiang Y; Sun H; Qiu B; Li C; Liu B; Li Q; Zhang L; Bai X; Wei Y; Li C; Wang R; Wang J
J Robot Surg; 2024 May; 18(1):219. PubMed ID: 38771389
[TBL] [Abstract] [Full Text] [Related]
10. Radiotherapy and immunology.
Wang L; Lynch C; Pitroda SP; Piffkó A; Yang K; Huser AK; Liang HL; Weichselbaum RR
J Exp Med; 2024 Jul; 221(7):. PubMed ID: 38771260
[TBL] [Abstract] [Full Text] [Related]
11. The effect of liver metastases on clinical efficacy of first-line programmed death-1 inhibitor plus chemotherapy in esophageal squamous cell carcinoma: A post hoc analysis of ASTRUM-007 and meta-analysis.
Gao J; Song Y; Kou X; Tan Z; Zhang S; Sun M; Zhou J; Fan M; Zhang M; Song Y; Li S; Yuan Y; Zhuang W; Zhang J; Zhang L; Jiang H; Gu K; Ye H; Ke Y; Qi X; Wang Q; Zhu J; Huang J
Cancer Med; 2024 May; 13(10):e7203. PubMed ID: 38769930
[TBL] [Abstract] [Full Text] [Related]
12. Survival Predictive Nomograms for Non-Surgical Brain Metastases Patients From Non-Small Cell Lung cancer Receiving Radiotherapy: A Population-Based Study.
Li P; Luo J; Zheng Z; Meng L; Zhang A; Cao W; Gong X
Cancer Control; 2024; 31():10732748241255212. PubMed ID: 38769789
[TBL] [Abstract] [Full Text] [Related]
13. Guidelines for the clinical application of the
Tang H; Lu Q; Feng S; Xiao Z; Wu W; Chen G; Deng L; Yu T; Wu J; Lin H; Ji B; Lin J; Zhang C; Li L; Liu T; Ouyang Y; Lei K; Chen J; Peng W; Qiu Z; Cai Q; Liang Q; Liu C; Li Y; Zhu L; Zhang Z; Liu X; Lin L; Zheng Z
Pharm Biol; 2024 Dec; 62(1):472-479. PubMed ID: 38769628
[TBL] [Abstract] [Full Text] [Related]
14. Effect of cytokines on advanced hepatocellular carcinoma prognosis receiving radiotherapy and tislelizumab plus anlotinib: a single-center phase II clinical trial.
Lin YD; Wu GS; Rao MY; Liu YH; Han YW; Zhang J; Zhang JW
Sci Rep; 2024 May; 14(1):11486. PubMed ID: 38769368
[TBL] [Abstract] [Full Text] [Related]
15. Angiotensin-converting enzyme 2 and AMPK/mTOR pathway in the treatment of liver fibrosis: Should we consider further implications?
Barone M
World J Gastroenterol; 2024 May; 30(18):2391-2396. PubMed ID: 38764773
[TBL] [Abstract] [Full Text] [Related]
16. Assessment of safety and efficacy of transarterial chemoembolization combined with camrelizumab and donafenib in patients with hepatocellular carcinoma at BCLC stage C: A study of 20 cases.
Wang X; Yang Y
Medicine (Baltimore); 2024 May; 103(20):e38174. PubMed ID: 38758900
[TBL] [Abstract] [Full Text] [Related]
17. Overexpression of wild-type HRAS drives non-alcoholic steatohepatitis to hepatocellular carcinoma in mice.
Ling C; Liu SS; Wang YY; Huo GT; Yang YW; Xu N; Wang H; Wu Y; Miao YF; Fu R; Zhao YW; Fan CF
Zool Res; 2024 May; 45(3):551-566. PubMed ID: 38757223
[TBL] [Abstract] [Full Text] [Related]
18. Epstein
Peng L; Peng X; Duan S; Zhang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 49(2):319-330. PubMed ID: 38755729
[TBL] [Abstract] [Full Text] [Related]
19. Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.
Leek LVM; Notohardjo JCL; de Joode K; Velker EL; Haanen JBAG; Suijkerbuijk KPM; Aarts MJB; de Groot JWB; Kapiteijn E; van den Berkmortel FWPJ; Westgeest HM; de Gruijl TD; Retel VP; Cuppen E; van der Veldt AAM; Labots M; Voest EE; van de Haar J; van den Eertwegh AJM
Sci Rep; 2024 May; 14(1):11244. PubMed ID: 38755213
[TBL] [Abstract] [Full Text] [Related]
20. Second Chance for Cure: Stereotactic Ablative Radiotherapy in Oligometastatic Disease.
Salim N; Tumanova K; Popodko A; Libson E
JCO Glob Oncol; 2024 May; 10():e2300275. PubMed ID: 38754052
[TBL] [Abstract] [Full Text] [Related]
[Next]
